期刊文献+

小儿颅内肿瘤多药耐药相关因素的表达及临床意义 被引量:2

Expression and clinic significance of drug resistance-associated factors in intracranial tumors of children
原文传递
导出
摘要 目的 本实验旨在通过不同类型的小儿颅内肿瘤中多药耐药相关因素的表达情况分析 ,探讨小儿颅内肿瘤化疗疗效较差的原因以及血脑、血肿瘤屏障与颅内肿瘤耐药性的关系 ,以寻求克服这些耐药因素的策略 ,提高颅内肿瘤化疗疗效。方法 标本选自重庆医科大学附属儿童医院及附属第一医院近 3年存档的小儿颅内肿瘤标本共 5 2例 ,星形细胞瘤 8例 ,分化不良的星形细胞瘤 8例 ,多形性胶质母细胞瘤 8例、脑膜瘤 8例、髓母细胞瘤 10例和颅咽管瘤 10例 ,此外还作了 5例正常脑组织作对照。所有患儿均为初诊 ,年龄 1~ 18岁 ,中位年龄 5岁 ,男∶女 =2∶1。 2 9例获随访资料 ,随访时间 2个月~ 3年 ,术后生存期自手术日至失访或死亡日止。应用SP免疫组化方法检测小儿颅内肿瘤中P gp、MRP、LRP、TopoIIα的表达。 结果 在所有检测的颅内肿瘤中P gp、MRP、LRP、TopoIIα的表达阳性率分别是 6 1.5 %、36 .5 %、2 6 .9%、36 .5 %。P gp、MRP、LRP在星形细胞瘤和髓母细胞瘤中主要表达于血管内皮细胞 ,而肿瘤细胞几乎不表达。但在脑膜瘤、颅咽管瘤中却没有这种差异。TopoIIα主要表达于肿瘤细胞核内 ,偶见其他细胞的散在弱阳性表达。 结论 小儿颅内肿瘤化疗失败的原因主要与血脑、血肿瘤屏障对化疗药物的阻滞以及肿瘤细胞本? Objective To determine if drug resistance is a possible cause of the low efficacy of chemotherapy in intracranial tumors of children.Methods Immunoreactivity of monoclonal antibodies to P-gp, MRP, LRP, Topo IIα were examined in intracranial tumors in 52 children by SP immunohistochemistry.Results The intracranial tumors expressed P-gp, MRP, LRP, Topo II, with positive rates being 62.5%, 36.5%, 26.9% and 36.5%, respectively, irrespective of the tumor type. P-gp, MRP, LRP demonstrated strong cytoplasmic expression in endothelial cells of the small blood capillaries in the astrocytoma and medulloblastoma. In contrast, they were almost absent in tumor cells. However, significant difference in meningioma and craniopharyngioma was not found. The expression of topoisomerase IIα, predominantly was associated with the nucleus in tumor cells. Besides, there was occasionally weak immunostaining in the others. Conclusions Several reasons have been proposed as an explanation for the low efficacy of chemotherapy in intracranial tumors of children. The entry of drugs into the brain has been strictly regulated by blood-brain barrier or blood-tumor barrier and intrinsic drug resistance at the tumor cell level. Different intracranial tumors of children have different characteristics of drug resistance. If the resistance mechanisms could be manipulated, the efficacy of chemotherapy will be highly improved.
出处 《中华小儿外科杂志》 CSCD 北大核心 2004年第1期13-17,共5页 Chinese Journal of Pediatric Surgery
基金 国家自然科学基金资助项目 (项目编号 :3 0 0 70 781)
关键词 小儿 颅内肿瘤 多药耐药 临床意义 化疗 单克隆抗体 P-glycoprotein MRP LRP Topo IIα Children's Intracranial tumor
  • 相关文献

参考文献1

二级参考文献10

  • 1KiwitJCW,HertelA,AlexanderE,etal.Reversalofchemoresistanceinmalignantgliomasbycalciumantagonists :correlationwiththeexpres sionofmultigrug resistantP glycoprotein[].JNeurosurg.1994 被引量:1
  • 2FojoAT,UedaK,SlamonGJ,etal.Expressionofmultidrugresistancegeneinhumantumorsandtissues[].Proceedings of the National Academy of Sciences of the United States of America.1987 被引量:1
  • 3BiningN,MillerRA.LytokineproductionbysubsetsofCD4memoryTcellsdifferinginP glycoproteinexpression :effectsofaging[].JGerontolABiolSciMedSci.1997 被引量:1
  • 4CardoCC,O brienJP,BocciaJ,etal.Expressionofmultidurgresist tancegeneproduct (P glycoprotein)inhumannormalandtumortissues[].Journal of Histochemistry and Cytochemistry.1990 被引量:1
  • 5NeuweltEA.Osmoticbloodbrainbarriermodificationandcombinationchemotherapy :currenttumorregressioninareasofbarrieropening[].Neurosurgery.1984 被引量:1
  • 6SchlaiferD,LaurentG,ChittalS,etal.ImmurohistochemicaldetectionofmultidurgresistanceassciatedP glycoproteinintumorandstromalcellsofhumancancers[].British Journal of Cancer.1990 被引量:1
  • 7FavrotM,CombaretV,GoillotE,etal.Expressionofp glycoproteinrestrictedtonormalcellsinneuroblastomabiposies[].British Journal of Cancer.1991 被引量:1
  • 8DeborahR,StephenC,ChristopherF,etal.Separationofdurgtrans portandchloridechannelfunctionofthehumanmultidrugresistanceP glycoprotein[].Cell.1992 被引量:1
  • 9CordonCardoJP,O brienD,Casals,etal.Multidrugresistancegene(P glycoprotein)isexpressedbyendothelialcellsatblood brainbarriessites[].Proceedings of the National Academy of Sciences of the United States of America.1989 被引量:1
  • 10NakanishiH,MyouiA,OchiT,etal.P glycoprteinexpressioninsoft tissuesarcomas[].JcancerResClinOncol.1997 被引量:1

共引文献7

同被引文献34

  • 1Rutka JT, Kuo JS. Pediatric surgical neuro-oncology: current best care practices and strategies. J Neurooncol. 2004,69:139-150. 被引量:1
  • 2Gutin PH, Posner JB. Neuro-oncology: diagnosis and manage ment of cerebral gliomaspast, present, and future. Neurosur gery, 2000, 47:1-8. 被引量:1
  • 3Filipits M, Suchomel RM, Dekam C, et al. Expression of the muitidrug resistance associated protein gene in colorectal carcino mas. Br J Cancer, 1997,75: 208-212. 被引量:1
  • 4Kleihues P,Cavenee WK. World Health Organization classification of tumours, Pathology and genetics of tumours of the nervous system. 3rd ed. Lyon: IARC Press, 2000. 107-110. 被引量:1
  • 5Begley DJ, Brightman MW. Structural and functional aspects of the blood-brain barrier. Prog Drug Res. 2003,61:39-78. 被引量:1
  • 6Gersmer ER, Fine RL. Increased permeability of the blood brain barrier to chemotherapy in metastatic brain tumors: establishing a t teat ment paradigm. J Clin Oncol, 20117, 25 : 23116-2312. 被引量:1
  • 7Trock BJ, Leonessa F, Clarke R. Multidrug resistance in breast cancer: a meta analysis of MDR1/p170 expression and its possb hie functional significance. Natl Cancer Inst, 1997,89:917-931. 被引量:1
  • 8Kubota H, Ishihara H, Langmann T, et al. Distribution and functional activity of P glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis. Epilepsy Res,2006, 68 : 213-228. 被引量:1
  • 9Pardridge WM, Golden PL, Kang YS,et al. Brain Microvascular and astrocyte localization of P glycoprotein . J Neurochem. 1997, 68: 1278-1285. 被引量:1
  • 10Tishler DM, Weinberg KI, Hinton DR, et al. MDR1 gene expression in brain of patients with medically intractable epilepsy. Epilepsia. 1995,36: 1-6. 被引量:1

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部